How many institutions held STRO - Sutro Biopharma, Inc. - Common Stock, par value $0.001 per share in Q1 2024?

116 institutional investors reported STRO - Sutro Biopharma, Inc. - Common Stock, par value $0.001 per share for Q1 2024. Use the holders table for investor-level position and value details.

Sutro Biopharma, Inc. - Common Stock, par value $0.001 per share (STRO)

Q: What does CUSIP 869367102 represent in this 13F holders report?

CUSIP 869367102 is the security identifier for STRO - Sutro Biopharma, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 869367102

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 16,182,923
Total 13F shares: 53,412,221
Share change: -2,312,906
Total reported value: $301,719,025
Put/Call ratio: 31%
Price per share: $5.65
Number of holders: 116
Value change: +$2,094,339
Number of buys: 67
Number of sells: 48

Quarterly Holders Quick Answers

What is CUSIP 869367102?
CUSIP 869367102 identifies STRO - Sutro Biopharma, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2024
Previous quarter: Q4 2023

Recent filing periods for CUSIP 869367102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of STRO - Sutro Biopharma, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	36%	5,823,922	$24,984,625	—	31 Dec 2023	13F
SUVRETTA CAPITAL MANAGEMENT, LLC	13F	Company	36%	5,778,188	$24,788,427	—	31 Dec 2023	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	28%	4,467,796	$19,166,845	—	31 Dec 2023	13F
BVF INC/IL	13F	Company	21%	3,347,946	$14,362,688	—	31 Dec 2023	13F
Rubric Capital Management LP	13F	Company	21%	3,344,810	$14,349,235	—	31 Dec 2023	13F
VANGUARD GROUP INC	13F	Company	18%	2,890,000	$12,398,101	—	31 Dec 2023	13F
FRANKLIN RESOURCES INC	13F	Company	17%	2,762,636	$11,851,709	—	31 Dec 2023	13F
Kynam Capital Management, LP	13F	Company	12%	2,001,727	$8,587,409	—	31 Dec 2023	13F
BAILLIE GIFFORD & CO	13F	Company	12%	1,866,850	$8,008,787	—	31 Dec 2023	13F
Samsara BioCapital, LLC	13F	Company	10%	1,675,579	$7,188,234	—	31 Dec 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	9.5%	1,535,869	$6,588,878	—	31 Dec 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	7.8%	1,259,237	$5,402,674	—	31 Dec 2023	13F
Parkman Healthcare Partners LLC	13F	Company	7.4%	1,202,431	$5,158,429	—	31 Dec 2023	13F
STATE STREET CORP	13F	Company	7.2%	1,161,465	$4,982,685	—	31 Dec 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	7%	1,140,760	$4,894,008	—	31 Dec 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	6.6%	1,060,582	$4,549,896	—	31 Dec 2023	13F
Eversept Partners, LP	13F	Company	6.5%	1,056,461	$4,532,218	—	31 Dec 2023	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	5.7%	923,029	$3,959,000	—	31 Dec 2023	13F
S.c.a. Candriam	13F	Individual	5.6%	898,234	$3,853,598	—	31 Dec 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	4.1%	655,797	$2,813,000	—	31 Dec 2023	13F
Vontobel Holding Ltd.	13F	Company	4%	641,684	$2,752,824	—	31 Dec 2023	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	3.9%	623,684	$2,675,604	—	31 Dec 2023	13F
Verition Fund Management LLC	13F	Company	3.8%	622,873	$2,672,125	—	31 Dec 2023	13F
NORTHERN TRUST CORP	13F	Company	3%	481,184	$2,064,280	—	31 Dec 2023	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	2.8%	451,692	$1,937,759	—	31 Dec 2023	13F
Pentwater Capital Management LP	13F	Company	2.8%	450,000	$1,930,500	—	31 Dec 2023	13F
Aquilo Capital Management, LLC	13F	Company	2.6%	420,649	$1,804,584	—	31 Dec 2023	13F
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)	13F	Company	2.3%	378,340	$1,623,079	—	31 Dec 2023	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	2.1%	340,283	$1,459,814	—	31 Dec 2023	13F
Schonfeld Strategic Advisors LLC	13F	Company	2.1%	338,600	$1,452,594	—	31 Dec 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	2%	323,192	$1,386,494	—	31 Dec 2023	13F
Opaleye Management Inc.	13F	Company	1.9%	301,491	$1,293,396	—	31 Dec 2023	13F
Point72 Asset Management, L.P.	13F	Company	1.8%	285,696	$1,225,636	—	31 Dec 2023	13F
DAFNA Capital Management LLC	13F	Company	1.7%	283,079	$1,214,409	—	31 Dec 2023	13F
Bank of New York Mellon Corp	13F	Company	1.6%	262,624	$1,126,657	—	31 Dec 2023	13F
TWO SIGMA ADVISERS, LP	13F	Company	1.5%	239,800	$1,028,742	—	31 Dec 2023	13F
Tejara Capital Ltd	13F	Company	1.4%	226,953	$973,628	—	31 Dec 2023	13F
MORGAN STANLEY	13F	Company	1.4%	223,924	$960,634	—	31 Dec 2023	13F
Nuveen Asset Management, LLC	13F	Company	1.3%	215,728	$925,473	—	31 Dec 2023	13F
Fisher Asset Management, LLC	13F	Company	1.2%	196,517	$843,057	—	31 Dec 2023	13F
Propel Bio Management, LLC	13F	Company	1.2%	195,000	$836,550	—	31 Dec 2023	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	1.1%	170,200	$730,158	—	31 Dec 2023	13F
PRUDENTIAL FINANCIAL INC	13F	Company	1%	169,220	$725,954	—	31 Dec 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.99%	160,876	$690,158	—	31 Dec 2023	13F
Exome Asset Management LLC	13F	Company	0.95%	153,600	$658,944	—	31 Dec 2023	13F
BARCLAYS PLC	13F	Company	0.82%	132,059	$566,533	—	31 Dec 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.82%	131,925	$565,958	—	31 Dec 2023	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.81%	131,242	$563,028	—	31 Dec 2023	13F
Simplify Asset Management Inc.	13F	Company	0.74%	120,000	$514,800	—	31 Dec 2023	13F
Man Group plc	13F	Company	0.74%	119,088	$510,888	—	31 Dec 2023	13F

Institutional Holders of Sutro Biopharma, Inc. - Common Stock, par value $0.001 per share (STRO) as of Q1 2024

As of 31 Mar 2024, Sutro Biopharma, Inc. - Common Stock, par value $0.001 per share (STRO) was held by 116 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 53,412,221 shares. The largest 10 holders included SUVRETTA CAPITAL MANAGEMENT, LLC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, MPM BIOIMPACT LLC, VANGUARD GROUP INC, Kynam Capital Management, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., BAILLIE GIFFORD & CO, Parkman Healthcare Partners LLC, and Samsara BioCapital, LLC. This page lists 116 institutional shareholders reporting positions in this security for the Q1 2024 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 holders

113

Q1 2024 holders

116

Holder diff

Investor	Q4 2023 Shares	Q1 2024 Shares	Share Diff	Share Chg %	Q4 2023 Value $	Q1 2024 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.